跳至主要内容
临床试验/JPRN-UMIN000009830
JPRN-UMIN000009830已完成4 期

Examination of the effectiveness of early diagnosis and treatment performed by magnetic resonance imaging (MRI) of hepatocellular carcinoma with liver specific contrast agent. - Examination of the effectiveness of early diagnosis and treatment of HCC by EOB-MRI

Gastroenterology of the university of Tokyo hospital0 个研究点目标入组 140 人开始时间: 2013年1月21日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Cases correspond to the following exclusion criteria at the time of registration are excluded from the scope. Cases of liver dysfunction or more points 9 Child-Pugh score Failure in patients with severe hepatic, there are reports that the rate of excretion into feces after administration of gadolinium has dropped to 6%. Patients with renal impairment than eGFR 30mL/min In patients with severe renal impairment, in patients who spoke a foreign nephrogenic systemic fibrosis after gadolinium-based contrast agent other use has been reported Patients with severe heart disease Patients with severe respiratory disease If the physician has deemed inappropriate sharing research or study investigator.

研究者

发起方
Gastroenterology of the university of Tokyo hospital

相似试验